Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Hummingbird Bioscience
Nektar Therapeutics
Akeso
GlaxoSmithKline
Washington University School of Medicine
Eisai Inc.
NKGen Biotech, Inc.
UNICANCER
Radboud University Medical Center
University of Texas Southwestern Medical Center
National University Hospital, Singapore
Dana-Farber Cancer Institute
Novartis
Emory University
National Cancer Institute (NCI)
University of Tennessee Cancer Institute